Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials
click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.


Alan Franciscus

Editor-in-Chief

HCV Advocate



Saturday, May 9, 2015

UK: NHS denies lifesaving drug to 5,000 patients it gave infected blood: Sofosbuvir has been approved by regulators but victims are STILL waiting for treatment

  • Thousands of victims were infected by hepatitis C through imported blood 
  • Breakthrough drug Sofosbuvir was approved by regulator NICE in January 
  • But NHS England is delaying treatment for patients until at least August 

Thousands of patients who contracted a deadly disease through contaminated blood in the biggest scandal in NHS history are being denied a lifesaving drug.

About 7,500 victims are known to have been infected with hepatitis C in the 1970s and 1980s through imported blood products taken from high-risk donors such as prostitutes and prisoners.

A breakthrough drug called Sofosbuvir was approved in January by drugs regulator NICE and patients were told they would have to wait until April to get the ten-week course of tablets, which costs £45,000. 

But NHS England has decided on a further delay until August to ensure all patients have equal access to treatment.

No comments:

Post a Comment